Skip to search.
 FTSE 100 Down 0.67%

More On OXB.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Oxford BioMedica PLC (OXB.L)

-LSE Ticker: 664815/ISIN: GB0006648157
9.20 0.00(0.00%) 3 Jul 16:35
Add to Portfolio
Prev Close:9.20
Open:8.85
Bid:9.19
Ask:9.21
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:8.85 - 9.33
52wk Range:2.63 - 13.38
Volume:3,892,866
Avg Vol (3m):4,477,010
Market Cap:236.23m
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,728.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.25
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines. Its LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple ther... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback